Acadia Pharmaceuticals Inc (ACAD)

Total Costs & Expenses

$1.05B

TTM · Period ending: · USD

ACAD logo

ACAD Total Costs & Expenses

Latest reported$1.05B
ACAD TTM Total Costs & Expenses (-$12.66M → $1.05B)
High-resolution chart · PNG

ACAD total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Acadia Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
1,052,276,000
1,014,345,000
966,694,000
806,195,000
782,075,000
761,409,000
727,003,000
817,001,000
867,719,000
818,391,000
799,816,000
786,272,000
678,377,000
684,393,000
740,831,000
733,693,000
719,026,000
709,742,000
654,584,000
667,338,000
726,901,000
722,084,000
728,341,000
694,897,000
628,428,000
614,611,000
585,621,000
557,742,000
537,311,000
518,157,000
471,251,000
457,976,000
440,289,000
418,056,000
418,461,000
395,083,000
370,861,000
343,972,000
290,146,000
245,535,000
206,905,000
174,383,000
164,673,000
147,693,000
133,665,000
115,918,000
93,350,000
76,949,000
62,991,000
50,848,000
39,441,000
34,439,000
29,273,000
25,693,000
25,793,000
24,496,000
24,288,000
25,304,000
24,919,000
25,292,000
26,158,000
25,707,000
27,040,000
31,240,000
35,906,000
43,954,000
51,867,000
55,928,000
61,090,000
65,669,000
69,374,000
75,126,000
78,605,000
74,043,000
70,209,000
65,244,000
59,876,000
59,963,000
57,187,000
55,006,900
57,010,900
51,274,200
46,762,600
42,158,500
33,576,300
31,469,000
30,699,500
1,042,300
-6,861,500
-9,438,900
-12,664,100
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.